The Discounted Cash Flow (DCF) valuation of INmune Bio Inc (INMB) is (60.17) USD. With the latest stock price at 7.76 USD, the upside of INmune Bio Inc based on DCF is -875.4%.
Based on the latest price of 7.76 USD and our DCF valuation, INmune Bio Inc (INMB) is a sell. selling INMB stocks now will result in a potential gain of 875.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.5% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (156.04) - (37.97) | (60.17) |
| Upside | -2110.8% - -589.3% | -875.4% |